Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.

Journal: Schizophrenia bulletin

Publication Year: 

Authors & Co-authors:  Wannan Nelson Addington Allott Anticevic Arango Baker Bearden Billah Bouix

Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies.

Journal: Brain, behavior, and immunity

Publication Year: 

Authors & Co-authors:  Byrne Healy Föcking Heurich Susai Mongan Wynne Kodosaki Woods Cornblatt